Last update 29 Aug 2025

SIMR (Australia) Biotech Pty Ltd

Overview

Tags

Nervous System Diseases
Other Diseases
Cardiovascular Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases3
Infectious Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug3
Top 5 TargetCount
Lp-PLA2(Lipoprotein-associated phospholipase A2)1
GABRA5(Gamma-aminobutyric acid A receptor alpha-5)1

Related

3
Drugs associated with SIMR (Australia) Biotech Pty Ltd
SR-419
Target-
Mechanism-
Active Org.
SIMR (Australia) Biotech Pty Ltd
Originator Org.
Shanghai SIMR Biotech Co., Ltd.Shanghai SIMR Biotech Co., Ltd.
Active Indication
Neuralgia
Inactive Indication
Neuralgia, Postherpetic
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
SR-750
Target
GABRA5
Mechanism
GABRA5 negative allosteric modulator
Active Org.
Shanghai SIMRD Biotechnology Co.,LtdShanghai SIMRD Biotechnology Co.,Ltd [+2]
Originator Org.
Shanghai SIMR Biotech Co., Ltd.Shanghai SIMR Biotech Co., Ltd.
Active Indication
Peripheral neuralgia [+3]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
SR-1375
Target
Lp-PLA2
Mechanism
Lp-PLA2 inhibitors
Active Org.
Shanghai SIMR Biotech Co., Ltd.Shanghai SIMR Biotech Co., Ltd. [+2]
Originator Org.
Shanghai SIMR Biotech Co., Ltd.Shanghai SIMR Biotech Co., Ltd.
Active Indication
Community Acquired Pneumonia [+5]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with SIMR (Australia) Biotech Pty Ltd
NCT04705077
/ CompletedPhase 1
A Phase 1, Open-Label Study to Assess the Single Dose Pharmacokinetics of Suspension and Capsule Formulations of SR419 and Repeat Dose Pharmacokinetics of Capsule Formulation of SR419, and to Assess the Effect of a High-Fat Meal on the Pharmacokinetics of SR419 in Healthy Subjects
100 Clinical Results associated with SIMR (Australia) Biotech Pty Ltd
Login to view more data
0 Patents (Medical) associated with SIMR (Australia) Biotech Pty Ltd
Login to view more data
100 Deals associated with SIMR (Australia) Biotech Pty Ltd
Login to view more data
100 Translational Medicine associated with SIMR (Australia) Biotech Pty Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Sep 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
2
1
Phase 2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
SR-419
Neuralgia
More
Phase 2
SR-1375
 ( Lp-PLA2 )		Diabetic macular oedema
More
Phase 1
SR-750
 ( GABRA5 )		Neuralgia
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free